My Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Healthcare Reporter.

Press releases published on August 6, 2026

Aug. 6, 2026

RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors

Indeterminate GlobeNewswire

Aug. 6, 2026

Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models

Indeterminate GlobeNewswire

Aug. 6, 2026

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Indeterminate GlobeNewswire

Aug. 6, 2026

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire

Aug. 6, 2026

MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates

Indeterminate GlobeNewswire

Aug. 6, 2026

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Aug. 6, 2026

VivoSim Provides Financial and Listing Compliance Update

Indeterminate GlobeNewswire

Aug. 6, 2026

Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium

Indeterminate GlobeNewswire

Aug. 6, 2026

Medecision Earns “Innovators” Distinction in Frost & Sullivan’s 2026 Frost Radar™ Report

Indeterminate GlobeNewswire

Aug. 6, 2026

Wondear Highlights Growing Demand for At-Home Red Light Therapy Wellness Solutions

Indeterminate EIN Presswire

Aug. 6, 2026

Theriva™ Biologics Announces First Patient Dosed in VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Indeterminate GlobeNewswire

Aug. 6, 2026

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference

Indeterminate GlobeNewswire

Aug. 6, 2026

Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases

Indeterminate GlobeNewswire

Aug. 6, 2026

vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 6, 2026

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 6, 2026

LENSAR® to Report Second Quarter 2026 Results on August 13th, 2026

Indeterminate GlobeNewswire

Aug. 6, 2026

Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Aug. 6, 2026

Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments

Indeterminate GlobeNewswire

Aug. 6, 2026

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

Indeterminate GlobeNewswire

Aug. 6, 2026

Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire